Keeping the Medical in Medical Marijuana

In the US, prescribers are faced with a blend of state laws regulating cannabis, with 29 states permitting “medical marijuana” 17 permitting cannabidiol only, and nine permitting “recreational”. Products available to patients range from FDA approved synthetic cannabinoids such as dronabinol, to non-FDA approved preparations ranging from extracts to crude plant products. Health care providers are further confused by public demand for medical and recreational marijuana, and a perception that cannabinoids have been proven safe and effective in the treatment of numerous conditions. This creates numerous challenges for both prescribers, pharmacists and patients, especially as the FDA acts to approve compounds and the DEA struggles to classify preparations newly approved by the FDA. Health care providers need education that encompasses both health effects of recreational and the evidence-based use of emerging compounds that includes discussion of efficacy, pharmacokinetics and adverse effects. 

• Describe the differences between recreational and medical marijuana and FDA approved cannabinoids
• Describe the pharmacokinetics of the major cannabinoids
• Identify potential drug interactions with major cannabinoids and adverse effects associated with medical and recreational marijuana
• List conditions for which evidence supports a use of cannabinoid therapy

This program contains both an online homestudy component and a live teleconference component.

The homestudy component contains a pre-test, education video presentation, educational reference material, post-test, and program evaluation.  A score of 70% is required to achieve successful completion of this component.

The live component consists of a teleconference, with identified discussion topics, and a Q&A session surrounding the subject matter.

(A calendar of dates are available to select for participation)

Edward M Bednarczyk, PharmD, FCCP, FAPhA

Clinical Associate Professor, Pharmacy Practice

Director,  cHOPE

President, APhA-APRS

Pharmacists and Prescribers  $50.00                                                     

Medical & Pharmacy Residents/Fellows   $40.00                              

Students   $20.00                                                           

PHARMACIST ACCREDITATION

The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been accredited as knowledge-based activity. Homestudy credit will be uploaded to the CPE Monitor for those who score 70% or better on the post-test and complete the program evaluation.

Live credit will be uploded to the CPE Monitor for those who participate in the teleconference discussion.

"Keeping the Medical in Medical Marijuana" ACPE#: 0044-0000-19-013-H01-P, 0044-0000-19-023-L01-P

PHYSICIAN ACCREDITATION

ACCREDITATION ENDURING PROGRAM

The University at Buffalo Jacobs School of Medicine and Biomedical Sciences is accredited by the ACCME to provide continuing medical education for physicians.

CERTIFICATION

The University at Buffalo Jacobs School of Medicine and Biomedical Sciences designates this Internet Enduring Material for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACCREDITATION LIVE PROGRAM

ACCREDITATION

The University at Buffalo Jacobs School of Medicine and Biomedical Sciences is accredited by the ACCME to provide continuing medical education for physicians.

CERTIFICATION

The University at Buffalo Jacobs School of Medicine and Biomedical Sciences designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Please email pharmacyce@buffalo.edu